Sukhatme Mayukh bought ROIV
December 17, 2025 · Form 4 insider transaction
Sukhatme Mayukh bought 59,513 shares of Roivant Sciences Ltd. at $12.68 per share, a transaction worth $754.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
59,513
Price
$12.68
Total value
$754.6K
InsiderSukhatme Mayukh
RoleOfficer, Director
CompanyRoivant Sciences Ltd. (ROIV)
SecurityCommon Shares
Transaction codeM: Option exercise
Transaction dateDecember 17, 2025
Filing dateDecember 19, 2025
Shares owned after18,896,060
OwnershipDirect
10b5-1 planNo
AmendedNo